{"id":"W4407393534","doi":"10.1016/j.annonc.2025.01.009","title":"VP1-2025: Datopotamab deruxtecan (Dato-DXd) vs chemotherapy (CT) in previously-treated inoperable or metastatic hormone receptor-positive, HER2-negative (HR+/HER2–) breast cancer (BC): Final overall survival (OS) from the phase III TROPION-Breast01 trial","year":2025,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Novartis; Pfizer","keywords":"Medicine; Metastatic breast cancer; Chemotherapy; Oncology; Breast cancer; Internal medicine; Hormone receptor; Cancer; HER2 negative; Mammary gland","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006556875,0.0006485858,0.002034266,0.0002749673,0.0001866528,0.00003635886,0.0005446753,0.0002132444,0.002808556],"category_scores_gemma":[0.000254126,0.0004574171,0.0002935091,0.001010145,0.0006332976,0.0003346332,0.0001436734,0.0007715566,0.00001998069],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006539889,"about_ca_system_score_gemma":0.002198874,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.03199148,"about_ca_topic_score_gemma":0.006413366,"domain_scores_codex":[0.9954457,0.0009889703,0.001240497,0.0009207588,0.0004877377,0.0009162952],"domain_scores_gemma":[0.9962773,0.001481929,0.0006317837,0.0007826153,0.0006002907,0.0002261003],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6060981,0.00575943,0.003612552,0.0001153814,0.003343319,0.0003099731,0.002594572,0.0001067321,0.006304222,0.0003287418,0.01151305,0.3599139],"study_design_scores_gemma":[0.7029072,0.02071577,0.098038,0.002399773,0.001501217,0.0003500876,0.003701292,0.0005402474,0.03706932,0.003379797,0.1277766,0.001620676],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9562943,0.003057479,0.0003345624,0.03459342,0.0005614388,0.003134578,0.001112836,0.00009072699,0.0008206523],"genre_scores_gemma":[0.9812277,0.006471612,0.001337282,0.006195905,0.0005680977,0.0008319481,0.0003988328,0.0001051607,0.002863484],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3582933,"threshold_uncertainty_score":0.9997877,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0593424706167068,"score_gpt":0.3971762921024471,"score_spread":0.3378338214857404,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}